[go: up one dir, main page]

ES2171416T3 - Remedio contra la trombocitopenia. - Google Patents

Remedio contra la trombocitopenia.

Info

Publication number
ES2171416T3
ES2171416T3 ES93919687T ES93919687T ES2171416T3 ES 2171416 T3 ES2171416 T3 ES 2171416T3 ES 93919687 T ES93919687 T ES 93919687T ES 93919687 T ES93919687 T ES 93919687T ES 2171416 T3 ES2171416 T3 ES 2171416T3
Authority
ES
Spain
Prior art keywords
thrombocitopenia
remedy against
remedy
indolocarbazol
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93919687T
Other languages
English (en)
Inventor
Tatsuya Tamaoki
Yukimasa Shiotsu
Chikara Murakata
Shiro Akinaga
Masami Okabe
Yutaka Saitoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Application granted granted Critical
Publication of ES2171416T3 publication Critical patent/ES2171416T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/06—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

UN REMEDIO DE TROMBOCITOPENIA QUE CONTIENE UN DERIVADO DEL INDOLOCARBAZOL REPRESENTADO POR LA FORMULA GENERAL (I) O UNA SAL DEL MISMO FARMACOLOGICAMENTE ACEPTABLE COMO INGREDIENTE ACTIVO, Y UN NUEVO DERIVADO DEL INDOLOCARBAZOL.
ES93919687T 1992-09-21 1993-09-20 Remedio contra la trombocitopenia. Expired - Lifetime ES2171416T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25094192 1992-09-21

Publications (1)

Publication Number Publication Date
ES2171416T3 true ES2171416T3 (es) 2002-09-16

Family

ID=17215289

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93919687T Expired - Lifetime ES2171416T3 (es) 1992-09-21 1993-09-20 Remedio contra la trombocitopenia.

Country Status (6)

Country Link
US (1) US5674867A (es)
EP (1) EP0630898B1 (es)
CA (1) CA2123895A1 (es)
DE (2) DE69331228D1 (es)
ES (1) ES2171416T3 (es)
WO (1) WO1994006799A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0675125A1 (en) * 1994-03-18 1995-10-04 Kyowa Hakko Kogyo Co., Ltd. A therapeutic agent for thrombocytopenia and indolocarbazole derivatives
US5604219A (en) * 1994-03-18 1997-02-18 Kyowa Hakko Kogyo Co., Ltd. Indolocarbazole derivatives that stimulate platelet production
EP0763041A1 (en) * 1994-06-01 1997-03-19 Novartis AG Indolocarbazole derivatives for sensitizing multidrug-resistant cells to antitumor agents
AU2565995A (en) * 1994-06-01 1995-12-21 Ciba-Geigy Ag Polycyclic lactam derivatives for sensitizing multidrug-resistant cells to antitumour agents
JPH10501526A (ja) * 1994-06-01 1998-02-10 チバ−ガイギー アクチェンゲゼルシャフト 多薬物耐性に対する作用物質としてのカルバゾール誘導体
US5650407A (en) * 1995-04-05 1997-07-22 Cephalon, Inc. Selected soluble esters of hydroxyl-containing indolocarbazoles
US5686444A (en) * 1995-04-05 1997-11-11 Cephalon, Inc. Selected soluble esters of hydroxyl-containing indolocarbazoles
US6875865B1 (en) 1996-06-03 2005-04-05 Cephalon, Inc. Selected derivatives of K-252a
UA67725C2 (en) 1996-06-03 2004-07-15 Cephalon Inc K-252a derivatives and a method for improvement of functioning and cell survival enhancement
US6127401A (en) 1998-06-05 2000-10-03 Cephalon, Inc. Bridged indenopyrrolocarbazoles
EP1201668A4 (en) * 1999-07-13 2003-05-21 Kyowa Hakko Kogyo Kk Staurosporine DERIVATIVES
US6653290B2 (en) * 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
US6610727B2 (en) * 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
US6677450B2 (en) * 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
BR0208322A (pt) * 2001-03-22 2004-10-13 Bristol Myers Squibb Co Derivados de açúcar citotóxixo seletivo da topoisomerase i de indolopirrolocarbazóis
EP1765313A2 (en) 2004-06-24 2007-03-28 Novartis Vaccines and Diagnostics, Inc. Compounds for immunopotentiation
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
TW200808739A (en) 2006-04-06 2008-02-16 Novartis Vaccines & Diagnostic Quinazolines for PDK1 inhibition
BRPI0820722A2 (pt) 2007-12-20 2015-06-16 Novartis Ag Derivados de tiazol usados como inibidores de pi 3 cinases
US8293753B2 (en) 2009-07-02 2012-10-23 Novartis Ag Substituted 2-carboxamide cycloamino ureas
AR082418A1 (es) 2010-08-02 2012-12-05 Novartis Ag Formas cristalinas de 1-(4-metil-5-[2-(2,2,2-trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il)-amida de 2-amida del acido (s)-pirrolidin-1,2-dicarboxilico
EA025011B1 (ru) 2011-01-31 2016-11-30 Новартис Аг ПУРИНЫ, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ mTOR КИНАЗЫ, ИХ ИСПОЛЬЗОВАНИЕ И ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
JP6059731B2 (ja) 2011-10-28 2017-01-11 ノバルティス アーゲー 新規プリン誘導体および疾患の処置におけるその使用
EP2849756A1 (en) 2012-05-16 2015-03-25 Novartis AG Dosage regimen for a pi-3 kinase inhibitor
PT3076969T (pt) 2013-12-06 2021-11-23 Novartis Ag Regime de dosagem de um inibidor de fosfatidilinositol 3- quinase seletivo para a isoforma alfa
TWI538914B (zh) * 2014-10-03 2016-06-21 國立交通大學 蛋白質激酶之選擇性抑制劑、其醫藥組成物及其用途
CN108472289A (zh) 2015-11-02 2018-08-31 诺华股份有限公司 磷脂酰肌醇3-激酶抑制剂的给药方案
WO2018060833A1 (en) 2016-09-27 2018-04-05 Novartis Ag Dosage regimen for alpha-isoform selective phosphatidylinositol 3-kinase inhibitor alpelisib
WO2022006220A1 (en) * 2020-07-02 2022-01-06 Baylor University Indolocarbazole analogs of staurosporine and methods of synthesis thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5373501A (en) * 1976-12-11 1978-06-30 Kitasato Inst Novel antibiotics amm2282 and process for preparing same
JPS6041489A (ja) * 1983-08-12 1985-03-05 Kyowa Hakko Kogyo Co Ltd 新規生理活性物質ｋ―２５２
JPS62120388A (ja) * 1985-11-19 1987-06-01 Meiji Seika Kaisha Ltd Ｓｆ−２３７０物質ハロゲン化誘導体とその製造法
JPS62155284A (ja) * 1985-12-27 1987-07-10 Kyowa Hakko Kogyo Co Ltd 生理活性物質ｋ−２５２の誘導体
JPS62220196A (ja) * 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd 新規物質ｕｃｎ―０１
JPH0826037B2 (ja) * 1987-01-22 1996-03-13 協和醗酵工業株式会社 生理活性物質ｋ−２５２の誘導体
JPH0826036B2 (ja) * 1987-01-22 1996-03-13 協和醗酵工業株式会社 生理活性物質ｋ−２５２の誘導体
DE3752123T2 (de) * 1987-03-09 1998-05-14 Kyowa Hakko Kogyo Kk Derivate des physiologisch aktiven mittels k-252
US5093330A (en) * 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
IL86632A0 (en) * 1987-06-15 1988-11-30 Ciba Geigy Ag Derivatives substituted at methyl-amino nitrogen
JPS6420388A (en) * 1987-07-14 1989-01-24 Nakatsuka Kogyo Method for expressing grain pattern on fabric
JPH07113027B2 (ja) * 1987-12-24 1995-12-06 協和醗酵工業株式会社 Ｋ−２５２誘導体
WO1989007105A1 (en) * 1988-02-04 1989-08-10 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives
JPH0372485A (ja) * 1989-05-23 1991-03-27 Asahi Chem Ind Co Ltd スタウロスポリンの誘導体
JPH03220194A (ja) * 1989-11-30 1991-09-27 Asahi Chem Ind Co Ltd スタウロスポリンカルボン酸誘導体
JPH04145085A (ja) * 1990-09-25 1992-05-19 Asahi Chem Ind Co Ltd スタウロスポリンのγ―ラクタム環誘導体とそのアンモニウム塩
AU2866992A (en) * 1991-10-10 1993-05-03 Schering Corporation 4'-(n-substituted-n-oxide)staurosporine derivatives
DE69326388T2 (de) * 1992-06-22 1999-12-30 Kyowa Hakko Kogyo Co., Ltd. Verfahren zur Herstellung von Staurosporin-Derivaten

Also Published As

Publication number Publication date
DE69331228T4 (de) 2002-09-05
WO1994006799A1 (fr) 1994-03-31
EP0630898A1 (en) 1994-12-28
EP0630898B1 (en) 2001-11-28
US5674867A (en) 1997-10-07
CA2123895A1 (en) 1994-03-31
DE69331228T2 (de) 2002-05-23
DE69331228D1 (en) 2002-01-10
EP0630898A4 (en) 1995-04-26

Similar Documents

Publication Publication Date Title
ES2171416T3 (es) Remedio contra la trombocitopenia.
ES2182852T3 (es) Derivados de prolinamida.
ES2159591T3 (es) Composicion de liberacion controlada.
DK0750618T3 (da) Oxazolidinonderivater og farmaceutiske præparater indeholdende dem
ES2066120T3 (es) Uso de derivados de bencimidazol como agentes antibacterianos.
ES2179071T3 (es) Agentes vasodilatadores perifericos que comprenden como principio activo derivados de la piperidina 4-amino n-acilada.
ES2153836T3 (es) Composicion enmascaradora del sabor de agentes farmaceuticos amargos.
CO4940450A1 (es) Formulaciones farmaceuticas que contienen voriconazol
MX9202328A (es) Composicion farmaceutica local que contiene un compuesto alilamina como el agente activo.
ES2172069T3 (es) Derivado tetrapeptidico.
HN1999000081A (es) Jarabe antihistaminico estabilizado
DE59400489D1 (de) Fungizide Wirkstoffkombinationen
ES2144403T3 (es) Derivados de tiazol como inhibidores de oxigeno activo.
CO4440476A1 (es) Composicion sinergistica que comprende una combinacion plaguicida de ingredientes activos .
PA8514401A1 (es) Nuevos derivados de piperazina
ECSP045133A (es) Benzoxazoles sustituidos y análogos como agentes estrogenicos
AR029185A1 (es) Derivado de naftiridina
ES2109993T3 (es) Derivados de 4-desoxi-4-epipodofilotoxina o sus sales farmaceuticamente aceptables.
ES2139071T3 (es) Agente insecticida y acaricida derivado del triazol y proceso para la produccion del mismo.
ES2081491T3 (es) Nuevo polipeptido y farmaco anti-vih preparado a partir de este polipeptido.
ES2152016T3 (es) Solucion oftalmica de pranoprofeno conteniendo amina organica.
ES2181927T3 (es) Derivados de 1-metilcarbapenem.
BRPI0317188A2 (pt) Novo derivado de 2,4-diamino-1,3,5-triazina
ES2174113T3 (es) Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales.
ES2111768T3 (es) Derivados de carboestirilo utilizados como agentes antiarritmicos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 630898

Country of ref document: ES